Advances in the Diagnosis, Pathogenesis, and Management of Fibromyalgia Syndrome PsychCast™

Fibromyalgia Syndrome: Presentation, Diagnosis, Differential Diagnosis, and Vulnerability (57:45 Minutes)

Author: I. Jon Russell, MD, PhD, and Karen G. Raphael, PhD

This is a 1 hour PsychCast™ podcast with an Internet component.

This CME Expert Review PsychCast™ is jointly sponsored by the Mount Sinai School of Medicine and MBL Communications.

Release Date: May 2008
Termination Date: May 31, 2010

Funding for this activity has been provided through an educational grant from Eli Lilly and Company and Pfizer Inc.

Faculty Affiliations and Disclosures:

Dr. Russell is associate professor of medicine and director of the University Clinical Research Center at the University of Texas Health Science Center in San Antonio, editor of the Journal of Musculoskeletal Pain, and emeritus founding president of the International MYOPAIN Society. Dr. Russell is a consultant to and on the advisory boards of Eli Lilly, Jazz, and Pfizer; is on the speaker’s bureaus of Ortho-McNeil and Pfizer; and receives research support from Eli Lilly, Jazz, Ortho-McNeil, and Pfizer. He is supported, in part, by the RGK Foundation of Austin Texas.

Dr. Raphael is associate professor and director of research in the Department of Psychiatry at New Jersey Medical School, University of Medicine and Dentistry of New Jersey and associate professor in the Department of Diagnostic Sciences at New Jersey Dental School, University of Medicine and Dentistry of New Jersey in Newark. Dr. Raphael is supported, in part, by National Institutes of Health grant DE13486.

This article references unlabeled or unapproved uses of duloxetine, pregabalin, and sodium oxybate.

Learning Objectives

• Describe how a clinician can quantify the severity of pain in a patient with fibromyalgia syndrome (FMS).
• Know how to distinguish between FMS and the myofascial pain syndrome.
• Learn the prevalence of FMS in the general population and in a variety of practice settings.
• Identify several medical conditions that exhibit a clinical association with FMS.
• Understand the role of traumatic stress in the pathogenesis of FMS.
• Appreciate the distinction between FMS as a “stress disorder” and a “stress vulnerability disorder.”

Target Audience: This activity is designed to meet the educational needs of psychiatrists.

Peer Reviewers:

Eric Hollander, MD, does not have an affiliation with or financial interest in any organization that might pose a conflict of interest. This activity has been peer-reviewed and approved by Eric Hollander, MD, Professor of Psychiatry and Chair at Mount Sinai School of Medicine. Review Date: February 15, 2008

Accreditation Statement: This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Mount Sinai School of Medicine and MBL Communications, Inc. The Mount Sinai School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: The Mount Sinai School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure Policy Statement: It is the policy of Mount Sinai School of Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Disclaimer: These are the opinions of the authors not of the sponsors or supporters. For more information, contact MBL Communications at cme@mblcommunications.com.

Minimum Hardware/Software Requirements

Macintosh: PowerPC processor, Mac OS 8.6, 9.0.4, 9.1, or Mac OS X, 64MB of RAM, 24MB of available hard-disk space, and Safari 1.x or 2.x.
Windows PC: Intel Pentium processor, Microsoft Windows 95 OSR 2.0, Windows 98 and 98 SE, Windows Millennium Edition, Windows NT 4.0 with Service Pack 5, Windows 2000, or Windows XP, 64MB of RAM, 24MB of available hard-disk space, and Internet Explorer 6.x and newer or Firefox 1.x and newer.

This CME Activity and Posttest information file is a PDF (Portable Document Format) document. To view this file, you will need Adobe Acrobat Reader, which is available free at www.adobe.com. Follow the instructions on that page to download and install the software.